Back to Search
Start Over
AbbVie gives up patent rights for Keltra antiviral treatment, FT reports
- Source :
- The Fly. March 23, 2020
- Publication Year :
- 2020
-
Abstract
- AbbVie is giving up its patents on Kaletra, a combination drug that is being studied as a coronavirus treatment, The Financial Times' Donato Paolo Mancini and Hannah Kuchler report. According [...]
- Subjects :
- Antiviral agents -- Intellectual property
Lopinavir -- Intellectual property
Patent law
Nongovernmental organizations
HIV
Physicians
Antiretroviral agents
Clinical trials
Medical research
Finance
Health
Public health
Business
News, opinion and commentary
Kaletra (Medication) -- Intellectual property
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.618300352